<DOC>
	<DOCNO>NCT00315614</DOCNO>
	<brief_summary>SPECIFIC AIMS : - To reverse hyperglycemia insulin dependency patient Type 1 diabetes mellitus islet cell transplantation . - To induce state donor specific tolerance eliminate need continuous immunosuppressive therapy simultaneous transplantation donor bone marrow cell islets utilization monoclonal antibody Campath-1H induction Immunosuppression . - To assess long-term function successful islet cell transplant patient Type 1 diabetes mellitus . - To determine whether natural history microvascular , macrovascular neuropathic complication alter follow successful transplantation islet</brief_summary>
	<brief_title>Islet Cell Transplantation Alone CD34+ Donor Bone Marrow Cell Infusion Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>In current protocol ( IRB # 2000/0024 ) immunosuppressive regimen , comprise induction daclizumab maintenance therapy sirolimus tacrolimus , combine infusion CD34+ enrich donor bone marrow stem cell attempt create chimeric state hence induce donor tolerance . This strategy test evaluate graft survival follow removal immunosuppressive medication one year .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Patients 18 65 year age 2 . Patients type 1 diabetes mellitus 5 year duration 3 . One following : Hypoglycemia unawareness judge history blood sugar &lt; 54 glucometer without symptom and/or hypoglycemic episode require assistance either family , glucagon administration emergency service Poor diabetes control ( HbA1c &gt; 8 % &gt; 2 visits/yr hospital treatment ketoacidosis ) despite intensive insulin therapy Progressive complication type 1 diabetes mellitus 4 . Body Mass Index ( BMI ) â‰¤26 1 . Untreated proliferative diabetic retinopathy ; 2 . HbA1C &gt; 12 % ; 3 . Insulin requirement &gt; 1.0u/kg/d 4 . Stimulated basal Cpeptide &gt; 0.3 ng/ml 5 . Creatinine clearance &lt; 60 and/or serum creatinine consistently &gt; 1.5mg/dl ; 6 . Macroalbuminuria &gt; 300mg albumin 24 hour 7 . Presence panel reactive antibody &gt; 20 % ; 8 . Previous/concurrent organ transplantation ( except fail islet cell transplantation ) ; 9 . Any medical condition require chronic use steroid ; 10 . Malignancy previous malignancy ( except nonmelanomatous skin cancer ) ; 11 . Xray evidence pulmonary infection ; 12 . Active infection ; 13 . Positive tuberculin test ( unless proof adequate treatment latent tuberculosis provide ) 14 . Active peptic ulcer disease , 15 . Gall stone and/or portal hypertension and/or hemangioma liver ultrasound ; 16 . Serological evidence HIV , HBV ( HBsAg+ and/or HBcAb+ and/or HBsAb+ without evidence vaccination ) , HTLV1 HCV ; 17 . Negative serology Epstein Barr virus ( EBV ) evidence acute infection ( IgM &gt; IgG ) ; 18 . Abnormal liver function test ; 19 . Anemia ( hemoglobin &lt; 12.0 g/dl ) ; 20 . Hyperlipidemia ( fast total cholesterol &gt; 240mg/dl and/or fast triglyceride &gt; 200mg/dl and/or fast LDL cholesterol &gt; 140mg/dl ) ; 21 . Body Mass Index 26 and/or weight &gt; 80kg ; 22 . Prostate specific antigen ( PSA ) &gt; 4 ng/ml ; 23 . Unstable cardiovascular status ( include positive stress echocardiography &gt; age 35 ) ; 24 . Active alcohol substance abuse ; 25 . Sexually active female : ) postmenopausal , b ) surgically sterile , c ) use acceptable method contraception ( oral contraceptive , Norplant , DepoProvera , barrier device acceptable ; condom use alone acceptable ) ; 26 . Positive pregnancy test intent future pregnancy , male subject 's intent procreate . 27 . Any condition circumstance make unsafe undergo islet cell transplant . 28 . History previous transplant previous bone marrow infusion . 29 . Persistent leucopenia ( white blood cell count &lt; 3,000/mm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Islet Transplantation</keyword>
</DOC>